VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer

Incidents per State

State Total
72,296
AK1,638
AL5,339
AR3,412
AS44
AZ13,316
CA58,147
CO11,002
CT7,824
DC1,626
DE1,670
FL36,235
FM3
GA13,429
GU82
HI2,195
IA4,332
ID2,473
IL19,261
IN22,568
KS4,284
KY6,945
LA4,714
MA13,886
MD11,901
ME2,997
MH8
MI17,865
MN11,345
MO8,919
MP30
MS2,676
MT2,147
NC15,401
ND1,273
NE2,732
NH2,859
NJ17,232
NM3,702
NV4,071
NY32,763
OH18,072
OK5,940
OR7,954
PA22,457
PR2,104
QM2
RI1,911
SC6,055
SD1,133
TN8,691
TX34,122
UT4,023
VA13,944
VI49
VT1,661
WA13,811
WI10,395
WV2,220
WY805
XB5
XL1
XV2

ID: 1254199
Sex: M
Age:
State: ME

Vax Date: 02/24/2021
Onset Date: 02/24/2021
Rec V Date: 04/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: minor allergic reaction; This is a spontaneous report from a contactable consumer (patient himself). A 71-year-old male patient received first dose of BNT162B2 (PFIZER BIONTECH COVID mRNA VACCINE, solution for injection, lot number: EN 6198) via an unspecified route of administration in right arm on 24Feb2021 at 10:45 (at the age of 71-year-old) as single dose for COVID-19 immunization. The patient medical history included High cholesterol and known allergies included Bee stings. The patient had no other vaccine in four weeks. Concomitant medication took in two weeks included simvastatin (SIMVASTATIN) dose of 10 mg on an unspecified date. On 24Feb2021 at 11:15, the patient experienced minor allergic reaction Face tingling, itchy right palm and Lips going numb. The patient not had covid prior vaccination; not tested covid post vaccination. The patient did not receive any treatment for the events. The outcome of the events was recovered on an unspecified date. No follow-up attempts are possible. No further information is expected.

Other Meds: SIMVASTATIN

Current Illness:

ID: 1254200
Sex: M
Age:
State: KS

Vax Date: 02/16/2021
Onset Date: 02/21/2021
Rec V Date: 04/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: joint and muscle ache and pain in arms, legs and buttocks began to be noticeable February 21, 2021; joint and muscle ache and pain in arms, legs and buttocks began to be noticeable February 21, 2021; This is a spontaneous report from a contactable consumer or other non hcp (Patient). A 71-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EL9266) via an unspecified route of administration at arm left on 16Feb2021 13:00 as single dose for COVID-19 immunization. The patient was not diagnosed with COVID-19 prior to vaccination. Medical history included prostatic disorder, Rx control for prostate and cholesterol, blood cholesterol abnormal. Concomitant medications included finasteride (FINASTERIDE) and rosuvastatin (ROSUVASTATIN). On 21Feb2021 the patient experienced joint and muscle ache and pain in arms, legs and buttocks began 07:00 and has been escalating each day since then, the aches and pain are becoming unbearable while moving, or walking. The outcome of the event aches and pain are becoming unbearable while moving, or walking was unknown and rest events was not recovered.

Other Meds: FINASTERIDE; ROSUVASTATIN

Current Illness:

ID: 1254201
Sex: M
Age:
State: OH

Vax Date: 02/25/2021
Onset Date: 02/26/2021
Rec V Date: 04/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: I started feeling discomfort from my fracture. By 36 hours I had great discomfort; pain with some swelling.; pain with some swelling.; This is a spontaneous report from a contactable consumer (patient). A 70-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EN6202), second dose via an unspecified route of administration, administered in right arm on 25Feb2021 07:45 as single dose for covid-19 immunization. The patient was 70 years old at the time of vaccination. Medical history included osteoarthritis and on 27 Jan2021 patient fell and have displace fragment of the 5th metacarpal base. Patient had no known allergies. On 04Feb2021 at 8:00 am patient received first dose of Bnt162b2 (lot number EL9265) in right arm. The patient was not test positive for Covid prior to or post vaccination. Concomitant medications included ROSUVASTATIN, FAMOTIDINE, AMLODIPINE BESYLATE and losartan potassium (LO), all taken on unspecified date and unknown if ongoing. On 26Feb2021 about 34 hours after the shot on 25Feb, the patient started feeling discomfort from his fracture. By 36 hours he had great discomfort and pain with some swelling. More pain than with the original fracture /fall. Talked with OSU vaccine hotline at around 36 hours after shot. They advised he talk with Doctor. He called doctor and was advised elevation, two ibuprofen and on Tylenol every 4 to 6 hours. He did that and after 57 hours out from shot, extreme pain gone, have swelling and some discomfort. Not yet to pre-shot levels of comfort but great improvement. Only took two rounds of ibuprofen and Tylenol. Outcome of the events was recovering. No follow-up attempts are possible. No further information is expected.

Other Meds: ROSUVASTATIN; FAMOTIDINE; AMLODIPINE BESYLATE; LO

Current Illness:

ID: 1254202
Sex: F
Age:
State: OR

Vax Date: 01/06/2021
Onset Date: 01/01/2021
Rec V Date: 04/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: I had a slight tightness of heart; Nausea; This is a spontaneous report from a contactable Other-Health Care Professional. A 39-years-old female patient (who was not pregnant at the time of vaccination), received bnt162b2 (PFIZER-BIONTEC COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration, on 06Jan2021 (Batch/Lot number was not reported), as SINGLE DOSE for covid-19 immunisation. Patient did not receive other vaccine in four weeks of vaccination. Patient did not receive Other medications in two weeks of vaccination. Medical history included, the patient previously took doxycycline and caffeine, experienced drug hypersensitivity and allergy to raw tomatoes and peach peels. There were no concomitant medications. In Jan2021, the patient experienced a slight tightness of heart (chest discomfort) and nausea. The patient underwent lab tests and procedures which included COVID-19 Nasal Swab test and COVID PCR both were negative on 10Feb2021. The outcome of the events were recovered on an unspecified date in Jan2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1254203
Sex: F
Age:
State: IL

Vax Date: 02/20/2021
Onset Date: 02/20/2021
Rec V Date: 04/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: intermittent lightheadedness; migrating sensation of tingling over body & face; bowel urgency; warm flush; though very fatigued; coldness of feet, then hands; This is a spontaneous report received from a contactable Other-Health Care Professional (patient). A 57-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VAC-CINE, Formulation: solution for injection, lot number: EN6201 and Expiry date was not reported), via an unspecified route of administration in left arm on 20Feb2021 as single dose for COVID-19 immunization. The patient medical history included Hypothyroid, Hypertension, Menopause and Shrimp allergy were reported. The patient concomitant medications Synthroid, Telmisartan/HCTZ, Prempro were reported. No other vaccination in four weeks. Patient did not have covid prior vac-cination. On 20Feb2021 Immediate post vaccination onset of intermittent lightheadedness and mi-grating sensation of tingling over body & face; at 45 minutes also experienced a sequence of cold-ness of feet, then hands (w/decreased perfusion), as those resolved then core/trunk, as trunk warmed then at 75 min upper gums, then eyelids, then nose; bowel urgency; at 2 hours warm flush, mind clearer, better color vision, feeling stronger; lightheadedness resolved within 3 hours of pharmacist observation. No urticaria, angioedema or respiratory distress. No treatment. Could stand and walk with assistance, though very fatigued. Rested at home. Re-presentation of light-headedness & tingling on 22Feb & again mildly on 24Feb while resting. Patient did not receive any treatment for adverse event. Patient did not tested covid post vaccination. The outcome for event peripheral coldness was recovered and for events dizziness, paraesthesia, Anal incontinence, Hot flush, Fatigue was recovering. No follow-up attempts are possible; No further information is expected.

Other Meds: SYNTHROID; TELMISARTAN/HCTZ; PREMPRO

Current Illness:

ID: 1254204
Sex: F
Age:
State: NC

Vax Date: 02/16/2021
Onset Date:
Rec V Date: 04/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Vertigo occurring 10 days after each injection; This is a spontaneous report from a contactable consumer (herself). A 70-years-old female patient received second dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route of administration, administered in arm left on 16Feb2021 at 14:45 as single dose for covid-19 immunisation. Patient did not take other medication in four week. The patient medical history and concomitant medication(s) included alirocumab (PRALUENT), fluticasone furoate, vilanterol trifenatate (BREO ELLIPTA). Historical Vaccine included first dose of bnt162b2. On an unspecified date, the patient had vertigo occurring 10 days after each injection. Patient took other medications in two weeks was included praluent, BREO, allergy medications and vitamins. The outcome of the event was recovering. Information about lot/batch number has been requested.

Other Meds: PRALUENT; BREO ELLIPTA

Current Illness:

ID: 1254205
Sex: F
Age:
State: NM

Vax Date: 02/10/2021
Onset Date: 02/12/2021
Rec V Date: 04/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Severe GI cramping; diarrhea; nausea; This is a spontaneous report from a contactable nurse, the patient. A 40-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 2 via an unspecified route of administration, administered in Arm Right on 10Feb2021 12:15 (Batch/Lot Number: EN6201) (at the age of 40-years-old) as single dose for covid-19 immunisation. The patient medical history included none. The patient had no known allergies. There were no concomitant medications. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1, administered in Arm Right on 20Jan2021 11:00 (Batch/Lot Number: EL-9261) (at the age of 40-years-old) for covid-19 immunisation. On 12Feb2021 03:00, the patient experienced severe GI cramping, diarrhea and nausea. The events resulted in emergency room/department or urgent care. Therapeutic measures were taken as a result of events included 2 litres of fluids, IV, IM and po medications. The outcome of the events was recovering.; Sender's Comments: Based on temporal association and know drug profile a contributory role of BNT162B2 to the reported severe GI cramping, diarrhea and nausea cannot be totally excluded. Case will be reassessed if additional information is received. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 1254206
Sex: F
Age:
State: CO

Vax Date: 02/21/2021
Onset Date: 02/26/2021
Rec V Date: 04/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: 5 days after the 2 vaccine I experienced large swelling in the lymph node area between my jaw and ear lobe on the right side. My vaccine was on the left arm.; This is a spontaneous report from a contactable consumer. A 73-years-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EN6203), via an unspecified route of administration, administered in left arm on 21Feb2021 12:00 as single dose for covid-19 immunisation. Medical history included tachycardia. Concomitant medication(s) included aspirin, amlodipine, omeprazole, Multivitamin and Vita. The patient previously took tetracycline, tramadol and codeine for all experienced drug hypersensitivity. The patient was not pregnant at the time of vaccination. The patient had no other vaccine in four weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 26Feb2021 18:00, the patient experienced 5 days after the 2 vaccine I experienced large swelling in the lymph node area between my jaw and ear lobe on the right side. My vaccine was on the left arm. The patient did not receive any treatment. Outcome of event was not recovered. No follow up attempts are possible. No further information is expected.

Other Meds: ASPIRIN [ACETYLSALICYLIC ACID]; AMLODIPINE; OMEPRAZOLE

Current Illness:

ID: 1254207
Sex: F
Age:
State: NY

Vax Date: 01/22/2021
Onset Date: 01/01/2021
Rec V Date: 04/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This is a spontaneous report from a contactable consumer (patient). A 94-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), first dose via an unspecified route of administration on 22Jan2021 (Batch/Lot Number: EL8982; Expiration Date: May2021) as single dose for covid-19 immunisation. Medical history included high blood pressure from an unknown date and unknown if ongoing. Concomitant medication included amlodipine besilate, benazepril hydrochloride (AMLODIPINE BENAZEPRIL) taken for an unspecified indication, start and stop date were not reported. The patient reported that she noticed after 2 or 3 days, she can't remember when she got a lump on her neck, 'she got the drug then the lump' (not clear nor clarified) then she had the second shot because she thought you know she didn't pay no attention to the lump. Second shot on the 12th and she still have the lump, so she went to the hospital and had a scan, she had dye put in her, they can't find nothing wrong with her and she was just wondering is it possible that this is one of the side effects. She had both shots. One was on 22Jan2021 and then on 12Feb2021. It was the Pfizer shots. She had no reaction and felt great. Her arm didn't hurt. She got a lump not on the side she got the shot but the other side of the neck. It is on the right side of the throat. The lump was smaller and seems bigger now. She noticed the lump about 2 to 3 days after she got first one. She didn't say anything to them because she wanted the second one. The shot was given on the left side, but the lump is on the right side. Sometimes it is below the chin and sometimes it seem in the middle. It seems like it moves. She can't see it when she looks in the mirror. Other people can feel it. She went to the doctor who sent her to hospital to get a scan. The lump was 9 x 20mm. The doctor said they should go further and get MRI with the dye. From that he couldn't find anything. He even checked the sinuses. Nothing is coming from her head or ear. There is no infection. They are kind of baffled. They sent her to the dentist to make sure it is not like an infection in the teeth. The dentist is also baffled. He is not stopping because he is concerned. He sent her to an oral surgeon. The oral surgeon doesn't want her to worry because of her age. He is not sure either. The oral surgeon didn't want her to do anything invasive. He said to wait until 16Mar2021 and come back and let him look at it. If he is still concerned and they will do biopsy. No one mentioned cancer but she is concerned and scared. The patient underwent lab tests and procedures which included investigation: unknown results on Jan 2021, magnetic resonance imaging: no reason for it or infection on an unspecified date, scan: can't find nothing wrong with me on an unspecified date, x-ray: no reason for it or infection on an unspecified date. Therapeutic measures were taken as a result of the event which included hot packs. The outcome of the event was unknown.Second dose given on 12Feb2021, lot number: EL9266, expires May 2021.

Other Meds: AMLODIPINE BENAZEPRIL

Current Illness:

ID: 1254208
Sex: F
Age:
State: NY

Vax Date: 02/21/2021
Onset Date: 02/01/2021
Rec V Date: 04/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: GI upset; nausea; abdominal pain; extreme tiredness; This is a spontaneous report from a contactable other HCP. A 73-years-old female patient received bnt162b2 ((PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, Lot Number: EL9269) via an unspecified route of administration, administered in left arm on 21Feb2021 14:30 as SINGLE DOSE for covid-19 immunization. Medical history included scleroderma and gastro esophageal reflux disease. Concomitant medications included omeprazole, metoprolol, crestor, zetia, and multivits. The patient previously took epinephrine and experienced drug hypersensitivity. On an unspecified date, the patient experienced GI upset. nausea, abdominal pain, and extreme tiredness. The outcome of the events was reported as recovered.

Other Meds: OMEPRAZOLE; CRESTOR; ZETIA; METOPROLOL

Current Illness:

ID: 1254209
Sex: F
Age:
State: NY

Vax Date: 02/20/2021
Onset Date: 02/20/2021
Rec V Date: 04/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Headache; Sleepy; This is a spontaneous report from a contactable consumer (patient). A 61-years-old non-pregnant female patient received of first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in right arm on 20Feb2021 14:45 (Lot Number: El9269 and Expiration date: Unknown) as single dose for covid-19 immunization. Medical history included lupus. Concomitant medications included hydroxychloroquine sulfate (PLAQUENIL [HYDROXYCHLOROQUINE SULFATE]), levothyroxine sodium (SYNTHROID) and esomeprazole sodium (NEXIUM [ESOMEPRAZOLE SODIUM]) for an unspecified indication. On 20Feb2021 at 18:15, patient experienced Headache and sleepy. 3-4 hours after receiving the shot the patient became so sleepy she could not hold her eyes open and felt like she was melting. The patient also had a slight headache for about 2 days. She did take a nap for about 1.5 hours - woke up for a couple hours and then went to bed for the night. she felt ok in the morning except for the slight headache. The outcome of the events was recovered. No follow-up attempts are possible. No further information is expected.

Other Meds: PLAQUENIL [HYDROXYCHLOROQUINE SULFATE]; SYNTHROID; NEXIUM [ESOMEPRAZOLE SODIUM]

Current Illness:

ID: 1254210
Sex: F
Age:
State: CA

Vax Date: 02/19/2021
Onset Date: 02/26/2021
Rec V Date: 04/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Hives one week after 2nd shot; This is a spontaneous report from a contactable consumer. A 73-year-old non-pregnant female patient received BNT162B2 (solution for injection) dose 2 via an unspecified route of administration, in left arm on 19Feb2021 at 11:30 as single dose for covid-19 immunization. Medical history included penicillin, Sulphur products. Historical vaccine included on 24Jan2021 BNT162B2 (product=COVID19; lot number: unknown; dose number 1; Anatomical location=Left arm). No prior vaccination of covid and no covid tested post vaccination. The patient's concomitant medications was not reported. On 26Feb2021 at 09:00, the patient experienced hives, one week after 2nd shot and there was no event treatment received for the event. The outcome of the event was not recovered. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1254211
Sex: M
Age:
State: MD

Vax Date:
Onset Date: 02/28/2021
Rec V Date: 04/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Open sore at injection site oozing clear fluid; This is a spontaneous report from a contactable consumer or other non-health care professional (patient). A 77-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot number: unknown Expiry date: unknown) via an unspecified route of administration in left arm on an unspecified date as single dose for COVID-19 immunization. Patient medical history included known allergies to penicillin, codeine. Patient concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 on 05Feb202 at 10:15 AM for COVID-19 immunization. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient did not receive any other medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient was not diagnosed with COVID-19. On 28Feb2021 at 08:30, patient experienced open sore at injection site oozing clear fluid. Patient did not receive the treatment for event. The outcome of the event was not recovered. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1254212
Sex: F
Age:
State: AL

Vax Date: 02/12/2021
Onset Date: 02/22/2021
Rec V Date: 04/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: covid test and it came back on 22Feb2021 as positive; What I understood is that if you had Covid, you are not supposed to be on the vaccine for 70 days. I cannot have it 90 days or something around that time after having a positive Covid test; This is a spontaneous report from a contactable consumer. A 46-years-old female patient received first dose of bnt162b2 (BNT162B2, Formulation: Solution for injection, Lot Number: EM9809) via an unspecified route of administration on 12Feb2021 at a single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient tested covid and it came back on 22feb2021 as positive. Patient thought that she is not supposed to be on the vaccine for 70 days. She cannot have it 90 days or something around that time after having a positive Covid test. The patient underwent lab tests and procedures which included Nasal swab test positive on 22Feb2021. Her second shot scheduled on 05Mar2021. The outcome of the events was unknown.

Other Meds:

Current Illness:

ID: 1254213
Sex: F
Age:
State: FL

Vax Date: 02/10/2021
Onset Date: 02/01/2021
Rec V Date: 04/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: I have been throwing up; This is a spontaneous report from a Pfizer sponsored program . A female patient of unspecified age (consumer) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) (Batch/LOT no unknown) dose 1 on unspecified date and second dose on 10Feb2021 via an unspecified route of administration as single dose for COVID-19 immunisation. The medical history and concomitant medication were not provided. Patient reported she just wanted to talk to somebody. Patient needed to start over with her situation she had been throwing up. patient needed to find out if this was related to vaccine. Patient was having an adverse reaction last 14Feb2021 and 19Feb2021. Product details (Lot, Expiration Date, NDC and UPC) and other consumer details could not be probed. Medical information had been requested. The outcome of the event was unknown. No follow up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1254214
Sex: M
Age:
State: TX

Vax Date: 02/25/2021
Onset Date: 02/25/2021
Rec V Date: 04/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Only for 1.5 days sore injection sight; This is a spontaneous report from a contactable consumer (patient). A 58-years-old male patient received BNT162B2 (Solution for injection, Lot number: EN6203) via an unspecified route of administration on the left arm on 25Feb2021 at 15:00 for Covid-19 Immunisation. The patient medical history included asthma and heart murmur. The patients concomitant medications were not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. No covid test post vaccination. No other vaccine in four weeks. On 25Feb2021 at 16:00 PM, the patient experienced sore injection site approximately 2 inches for 1.5 days. The patient did not receive any treatment for the event. The outcome of the event was recovered. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1254215
Sex: M
Age:
State: OK

Vax Date: 02/25/2021
Onset Date: 02/25/2021
Rec V Date: 04/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: hard to get a breath; anxious; my heart began to race; felt the urge to use the bathroom; This is a spontaneous report from a contactable consumer. A 37-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), via an unspecified route of administration, administered in arm right on 25feb2021 at 16:15 as single dose for covid-19 immunisation. Medical history and concomitant medications were not reported. No Known allergies. No other vaccine in four weeks. No other medications in two weeks. No covid prior vaccination. No covid tested post vaccination. On 25Feb2021 16:15 after about 1 minute she began to fill anxious, her heart began to race, and she noticed it was hard to get a breath. She also immediately felt the urge to use the bathroom. She raised her mask up slightly and was able to take deep breaths and she tried to calmly read the vaccine pamphlet as she thought maybe she was just nervous as she have never had a reaction before. No treatment received. The events outcome was recovered. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1254216
Sex: M
Age:
State: WA

Vax Date: 02/25/2021
Onset Date: 02/26/2021
Rec V Date: 04/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: cannot walk; left leg from hip to knee, severe ache; This is a spontaneous report from a contactable other-HCP (patient himself). A 65-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: EN6198) via an unspecified route of administration in left arm on 25Feb2021 16:30 as single dose for covid-19 immunization. Patient was 65-years-old at the time of vaccination. Patients medical history and concomitant medications were not reported. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced left leg from hip to knee, severe ache, cannot walk, very painful on 26Feb2021 05:00. No treatment received for reported adverse event. The outcome of the event was not resolved. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1254217
Sex: F
Age:
State: ID

Vax Date: 02/26/2021
Onset Date:
Rec V Date: 04/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Slight headache after shot into evening.; Slight nausea second night; Slight arm soreness on and off second and third day.; This is a spontaneous report from a contactable consumer. An unspecified age elderly (65+ Years) female patient (patient was not pregnant) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EL9266 and expiration date was not reported), via an unspecified route of administration in left arm on 26Feb2021 at 03:00 PM, at single dose for COVID-19 immunisation. The patient had medical history of High blood pressure and tachycardia. The concomitant medication included metoprolol, lovastatin, losartan and amlodipine besylate. It reported that, patient experienced slight headache after shot into evening, slight nausea second night and slight arm soreness on and off second and third day. Vaccine facility: Hospital. There was no other vaccine in four weeks and there is no treatment required to the adverse event. No COVID prior vaccination and not tested COVID post vaccination. The outcome of the events was recovering. No follow up attempts are possible. No further information is expected.

Other Meds: METOPROLOL; LOVASTATIN; LOSARTAN; AMLODIPINE BESYLATE

Current Illness:

ID: 1254218
Sex: F
Age:
State: NC

Vax Date: 02/28/2021
Onset Date: 02/28/2021
Rec V Date: 04/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: started having to clear throat; vocal changes; semi-wet cough; This is a spontaneous report from a contactable consumer. A 70-Year-Old Female Patient (non-pregnant) received first dose of of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EN8202), via an unspecified route of administration, administered at left arm, on 28Feb2021, 11:00 AM at single dose for COVID-19 immunisation. Patient medical history included cancer, lymphocytic colitis and PI 1 deficiency. Patient was known to allergies reactions. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications were not reported. The patient did not received other medications within 2 weeks of vaccination. On 28Feb2021, 45 min after administration, patient started having to clear throat, with vocal changes (hoarse voice went to a squeeky voice) with constant clearing of throat and semi-wet cough. Patient was treated with Benadryl, Epinephrine injectable and prednisolone. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, patient was not tested for COVID-19. The outcome of the evens are recovered on 28Feb2021. No follow up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1254219
Sex: F
Age:
State: OK

Vax Date: 02/27/2021
Onset Date: 02/27/2021
Rec V Date: 04/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This is a spontaneous report from a contactable consumer(patient). A 41-year-old female patient (non-pregnant at the time of vaccination) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: EN6202), via an unspecified route of administration on arm left on 27Feb2021 11:45 AM at single dose for COVID-19 immunization. The patient medical history included Polycystic Ovarian Syndrome and allergies to Sulfa Drugs. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines in 4 weeks. The patient Concomitant medications included ethinylestradiol, norethisterone (VYFEMLA), Prazosin, Buspirone, Metformin. On 27Feb2021 12:30 PM, the patient experienced Extreme fatigue, headache, achy joints, sore injection site, nausea. The lab test included PCR (Nasal swab), result: Negative on 05Feb2021. The patient did not receive any treatment for the events. The outcome of the events was reported as Recovering. No follow-up attempts are possible. No further information is expected.

Other Meds: VYFEMLA; PRAZOSIN; BUSPIRONE; METFORMIN

Current Illness:

ID: 1254220
Sex: M
Age:
State: OH

Vax Date:
Onset Date:
Rec V Date: 04/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: My voice has changed, mean to say it's higher; It is red and inflamed; It (rash) is red and inflamed; This is a spontaneous report received from a contactable pharmacist (Patient). A 81-years-old male patient received second dose of BNT162B2 (BNT162B2, Solution for injection, Batch/Lot Number: EL9264), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. Medical history included ongoing atrial fibrillation. The patient's concomitant medications were not reported. Patient stated that his voice has changed, it seems very, mean to say it's higher. he donot know if that is from it but the main thing he was calling about was a rash that I developed. Patient was treated with Benadryl for the itchy rash and he started a dose of Methylprednisolone. Reporter stated that the rash was red and inflamed. The outcome of the events was unknown.

Other Meds:

Current Illness: Atrial fibrillation (Verbatim: Atrial fibrillation)

ID: 1254221
Sex: F
Age:
State: FL

Vax Date: 02/08/2021
Onset Date: 02/21/2021
Rec V Date: 04/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: prone to sinus infections; Tested positive for COVID; This is a spontaneous report from a contactable Nurse. A 67-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot/Batch number: EL9262), dose 1 via an unspecified route of administration, administered in left deltoid on 08feb2021 at 3:15 PM as single dose for covid-19 immunisation. Medical history included sinusitis, diverticulitis. Concomitant medication(s) included levothyroxine sodium (LEVOXYL) taken for thyroid disorder, docusate sodium (COLACE) taken for diverticulitis; calcium carbonate, Vitamin D 2000 units, colecalciferol (vitamin d 2000). Her husband started not feeling well 1.5 weeks post vaccination. She specified her husband was also sneezing and she didn't have symptoms beside maybe a sinus congestion when waking up in the morning, which she has regularly. She said they are both prone to sinus infections (non serious), and her husband had a "sinus infection" with a "negative covid-19 test back in november. Due to having contact with her husband who had tested positive for COVID she also got tested for COVID. She mentioned she only goes out walking 3-4 miles each day, or bicycle 6-7 miles a day in the gym downstairs in their apartment complex. She has no symptoms whatsoever. She was not sleeping a lot with her husband because he was already in a different room due to his sleeping habits. She had a rapid COVID test done on 20Feb2021 and it was negative. On Saturday at the Urgent care she asked were the Rapid PCR test could be done. The rapid test was done via nasal swab. She had an oral COVID test done yesterday 21Feb2021 and it was positive. She has not had the second dose of the vaccine yet. The event assessed as medically significant. The outcome of the events was unknown.; Sender's Comments: Based on the temporal relationship, A possible contributory role of the suspect product to the development of Sinusitis cannot be excluded.,Linked Report(s) : US-PFIZER INC-2021218654 same reporter/drug, similar event, different patient

Other Meds: LEVOXYL; COLACE; VITAMIN D 2000

Current Illness:

ID: 1254222
Sex: F
Age:
State: OR

Vax Date: 02/20/2021
Onset Date: 02/20/2021
Rec V Date: 04/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: tickle in my throat; I had hives all over my chest; This is a spontaneous case is received from a contactable consumer or other non hcp reported for herself. A 24-years-old female patient (not pregnant) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection; Lot Number: UNKNOWN), via an unspecified route of administration, administered in Arm Left on 20Feb2021 15:15 (at the age of 24-years-old) as single dose for COVID-19 immunization. Medical history was none. Patient had no known allergies. Patient did not receive any other vaccine in two weeks of vaccination. Patient received unspecified other medications in two weeks of vaccination. Patient was not tested for covid prior to vaccination. It was reported that, on 20Feb2021 23:00, patient felt nothing physically until the evening after vaccination. She noticed around 11 PM that she had hives all over her chest (collarbone to bust to armpit) and on her back directly across from the front. They looked like red freckles almost. No pain, no itching, just hives. They were still on her body just less red. Now they look like freckles. Not sure when they developed. Thinking back, she did develop a tickle in her throat within 5 minutes. Patient was not tested for covid post vaccination. Outcome of the events was reported as recovering. Information about Lot/Batch number has been requested.

Other Meds:

Current Illness:

ID: 1254223
Sex: F
Age:
State: VA

Vax Date: 02/27/2021
Onset Date: 02/28/2021
Rec V Date: 04/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: it felt like my head would pop off at one point; hearing muffled; left ear was clogged and ringing; This is a spontaneous report from a contactable consumer. A 60-year-old non-pregnant female patient received dose of bnt162b2 (PFIZER BIONTECH COVID mRNA VACCINE, solution for injection, Lot Number: EN6205), via an unspecified route of administration, administered in arm Left on 27Feb2021 at 12:00 as SINGLE DOSE for covid-19 immunization. Medical history included Acid Reflux and known allergies to Bananas. The patient had no other vaccine in four weeks. Concomitant medication(s) in two weeks included rabeprazole (RABEPRAZOLE) taken 20 mg dose for an unspecified indication, start and stop date were not reported.The patient reported that about 28 hours after the vaccination her left ear was clogged and ringing and then both ears were clogged, and it felt like her head would pop off at one point. The patient was literally thought that she was going deaf. This had never happened to her before. It has gotten better at about 34 hours in, but left ear still feels clogged and hearing muffled. On 28Feb2021 at 16:00, the patient experienced hearing muffled and it felt like my head would pop off at one point and left ear was clogged and ringing. The patient not had covid prior vaccination; not tested covid post vaccination. The patient did not receive any treatment for the events. The outcome of the events is recovering. No follow-up attempts are possible. No further information is expected.

Other Meds: RABEPRAZOLE

Current Illness:

ID: 1254224
Sex: F
Age:
State: IL

Vax Date: 02/19/2021
Onset Date: 02/21/2021
Rec V Date: 04/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Bronchitis; This is a spontaneous report from a Pfizer-sponsored program VyndaLink Patient Support Hub from a contactable consumer A 82-years-old female patient received tafamidis (VYNDAMAX), NDC number: 0069873030 via an unspecified route of administration from 2020 (Batch/Lot number was not reported) and ongoing, at 61 mg, 1x/day for cardiac amyloidosis and bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 19Feb2021 (Batch/Lot Number: EN6200) as SINGLE DOSE for covid-19 immunisation. Medical history included body height decreased, carpal tunnel syndrome, cardiac amyloidosis (she has several heart conditions including cardiac amyloidosis). The patient's concomitant medications were not reported. The patient experienced bronchitis on 21Feb2021 with outcome of recovering. The action taken in response to the event for tafamidis was unknown. Therapeutic measures taken as a result of bronchitis are aspirin, lozenges and fluids. No follow-up attempts are possible. No further information is expected.

Other Meds: Vyndamax

Current Illness:

ID: 1254225
Sex: F
Age:
State: PA

Vax Date: 02/15/2021
Onset Date: 02/20/2021
Rec V Date: 04/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: itchy rash; eyes are itchy; blotches on both arms, under arms, some on her breasts, and buttocks, and some on knees and on her elbows; Rash; This is a spontaneous report received from a contactable consumer reported for herself. A 77-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: solution for injection,Lot number: EN6201) via an unspecified route of administration in left arm on 15Feb2021 as single dose for COVID-19 immunization. Patient medical history and Concomitant medications were not reported. No other products or investigation assessment was reported. On 20Feb2021,the patient experienced itchy rash, eyes are itchy, rash, blotches on both arms, under arms, some on her breasts, and buttocks, and some on knees and on her elbows, stated her eyes were itchy and where the rash was itching. Age at time of onset of reaction/event was reported as 81. Stated that she was due for her second dose on 8Mar2021. Reporter wanted to know if the rash will happen again with her second dose. The patient was not recovered from the event. Follow up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1254226
Sex: F
Age:
State: IL

Vax Date: 02/21/2021
Onset Date:
Rec V Date: 04/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: I had a terrible pain in my leg between the knee and the groin; This is a spontaneous report from a contactable consumer or other non hcp. A 83-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EL9269), first dose via an unspecified route of administration, administered in left arm on 21Feb2021 as SINGLE DOSE for covid-19 immunization. Patient medical history and concomitant medications were not reported. On an unspecified date approximately 14 hours later after her vaccination, early morning, she had a terrible pain in leg between the knee and the groin and it lasted for couple of minutes but it was very severe and she didn't know whether she should report this or not." She stated "my height is 5 feet 6 inch, I think I am shrunk and my weight is 210, more or less". Outcome of the event was unknown.

Other Meds:

Current Illness:

ID: 1254227
Sex: F
Age:
State: NM

Vax Date: 02/26/2021
Onset Date: 02/26/2021
Rec V Date: 04/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: the muscles in my neck got sorer; Diarrhoea; my legs were really red; flushed; Dizziness; This is a spontaneous report from a contactable consumer. A 75-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 26Feb2021 11:30 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. Medical history included irregular heartbeat, known allergies to sulfa drugs, wheat, dairy, eggs, and beans. Concomitant medication included metoprolol and gabapentin. It was reported that, on 26Feb2021, she received the shot about 11:30 AM she had to use the restroom and noticed that her legs were red and flushed at that point. She did not notice any rash. She had a couple of waves of dizziness which were short lived over the next couple of hours. she ran errands and ate lunch. She was fine after that. On 27Feb2021, she slept well and woke up OK. However, after breakfast, she was quite dizzy. She was able to walk around and when she dropped something on the floor, she was able to pick it up. she did have to pay attention to do these things. As the morning progressed, the muscles in her neck got sorer and sorer. she also had some diarrhea, which was not unusual for her. she called her doctor and spoke to a nurse, who said these mild reactions are not unusual and instructed her to document the symptoms. If they got worse, she was to call again, of course. All day, she was spacy and a bit dizzy; but she did take her dog for a mile walk. She has been under the weather all day. No fever, no rash and tired. The patient experienced my legs were red, flushed and dizziness on 26Feb2021, the muscles in my neck got sorer and diarrhoea on 27Feb2021. Outcome of the events was recovered. No follow-up attempts are Possible. Information on lot/batch cannot be obtained.

Other Meds: METOPROLOL; GABAPENTIN

Current Illness:

ID: 1254228
Sex: F
Age:
State: IL

Vax Date: 02/13/2021
Onset Date: 02/09/2021
Rec V Date: 04/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: tightness in chest; joint pain; headache; nausea; swollen lymph nodes; fatigue; itchy eyes; bacterial vaginosis; This is a spontaneous report from a contactable consumer. A 43-years-old female patient received bnt162b2 (BNT162B2), via an unspecified route of administration on 13Feb2021 12:00 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. The patient medical history was not reported. Concomitant medication included amlodipine besilate (AMLODIPINE BESILATE) taken for an unspecified indication,phentermine (PHENTERMINE) taken for an unspecified indication,metoprolol tartrate (METOPROLOL TARTRATE) taken for an unspecified indication, ascorbic acid (VIT C) taken for an unspecified indication, ergocalciferol (VIT D) taken for an unspecified indication. The patient experienced bacterial vaginosis with outcome of recovering. The patient had tightness in chest, joint pain, headache, nausea, swollen lymph nodes, fatigue, itchy eyes on 09Feb2021 with outcome of recovered. Information on the lot/batch number has been requested.

Other Meds: AMLODIPINE BESILATE; PHENTERMINE; METOPROLOL TARTRATE; VIT C; VIT D

Current Illness:

ID: 1254229
Sex: F
Age:
State: NJ

Vax Date: 02/11/2021
Onset Date: 02/12/2021
Rec V Date: 04/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: headache; This is a spontaneous report from a contactable consumer. A 74-year-old female patient (not pregnant) received bnt162b2 (UNSPECIFIED TRADE NAME, Solution for injection), dose 2 via an unspecified route of administration on 11Feb2021 (Batch/Lot Number: Unknown) at the age of 74 years old as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously received the first dose of bnt162b2 for covid-19 immunisation. No known allergies. No other vaccine in four weeks. On 12Feb2021, patient had headache for 2 days after getting the second dose of the vaccine. No treatment received for the event. No covid prior vaccination and no covid tested post vaccination. The outcome of the event was recovered on 14Feb2021. Information about the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1254230
Sex: M
Age:
State: FL

Vax Date:
Onset Date:
Rec V Date: 04/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: I have a rash; hives; itchy; This is a spontaneous report from a contactable consumer. This consumer reported similar events for 02 patients (Husband and wife). This is 2nd of 02 reports. This consumer (Patient's wife) reported for a male patient (Husband). A male patient of unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: unknown), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced rash, would call it hives, very itchy. Consumer further stated, her husband and she had got the same thing. they got shot and stuff together. And he had got the same, he got them two weeks ago. He had still got them, they are lessening. The outcome of events was recovering. Information on the Lot/Batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021218620 same drug/same event, different patient.

Other Meds:

Current Illness:

ID: 1254231
Sex: F
Age:
State: TX

Vax Date: 02/03/2021
Onset Date: 02/27/2021
Rec V Date: 04/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Tested positive for Covid 24 after second dose in vaccination series; Tested positive for Covid 24 after second dose in vaccination series; This is a spontaneous report from a contactable nurse. This 41-year-old female nurse (not pregnant) reported for herself that she received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection; Lot Number: EN5318), intramuscular, administered in Arm Right on 03Feb2021 as single dose for COVID-19 immunization. Medical history included known allergies: Sulfa drugs (drug hypersensitivity) from an unknown date and unknown if ongoing. Concomitant medication(s) included estradiol (ESTRADIOL) 1 mg daily taken for an unspecified indication, start and stop date were not reported. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection; Lot Number: E3249), intramuscular, administered in Arm Right on 13Jan2021 as single dose for COVID-19 immunization. The patient reported that she tested positive for covid 24 after second dose in vaccination series on 27Feb2021. No treatment received for the events. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 27Feb2021. Outcome of the events was unknown. Follow-up attempts are completed. No further information is expected.; Sender's Comments: The efficacy of a vaccine varies from patient to patient and can be affected by different factors; however, a contributory role of the suspect product BNT162B2 to the reported vaccination failure and COVID-19 cannot be ruled out.

Other Meds: ESTRADIOL

Current Illness:

ID: 1254232
Sex: F
Age:
State: MI

Vax Date: 02/22/2021
Onset Date: 02/22/2021
Rec V Date: 04/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: dull ache; Headache; This is a spontaneous report from a contactable consumer or other non hcp. A 65-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route of administration on 22Feb2021 (Batch/Lot Number: EL9267) as SINGLE DOSE for covid-19 immunisation. Medical history was none. There were no concomitant medications. The patient experienced headache on 22Feb2021, dull ache on an unspecified date. The reporter stated that she got her first dose yesterday, 22Feb2021. She says her adverse effect was that at 03:00PM or 03:30PM she was fine, then she took a nap and at 06:00PM she woke up with a big headache that she got to go away with an ice pack and a pill, then that night she had a dull headache. She says she didn't take another pill until the next morning, the headache is still here, it is a dull ache, it is not as worse as last night, it is annoying more than anything. Documented as provided. Caller says she took TYLENOL last night about 06:00PM then took another one this morning at 09:00AM. She says that the TYLENOL is 500mg, Extra Strength. UPC: Caller says this is not on the bottle, maybe it was on an outer box that was discarded a long time ago. LOT: SLA002, EXP: Jul2024. The events was considered as a non-serious. Therapeutic measures were taken as a result of headache and, dull ache. The outcome of the events was reported as unknown.

Other Meds:

Current Illness:

ID: 1254233
Sex: M
Age:
State: ME

Vax Date: 02/25/2021
Onset Date: 02/26/2021
Rec V Date: 04/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This is a spontaneous report from a contactable physician. A 76-year-old male patient received BNT162B2 (BNT162B2), dose 1 intramuscular on 25 Feb 2021 (Batch/Lot Number: EN6198) at single dose for COVID-19 immunization administered at clinic. Medical history included hypertension, blood cholesterol increased, myocardial infarction, colon cancer (had surgery for that and also had chemotherapy), coronary artery disease (30% blocked coronary artery), covid-19 from 19May2020 to an unknown date. Concomitant medication(s) included lisinopril for hypertension; amlodipine; rosuvastatin for blood cholesterol increased; evolocumab (REPATHA), subcutaneously at 140 mg (twice a month) for blood cholesterol increased. The patient reported, he was diagnosed positive with COVID-19 on 27May2020 from which he seem to have recovered without any residues of symptoms or side effect. He received first Pfizer COVID vaccination at noon time this past Thursday 25Feb in a vaccination clinic set up, the following day Friday the 26 he woke up the next morning and entire body was so sore from head to toe and could hardly get himself out of bed, but when he got up, he was having difficulty walking, so anyway he stayed in bed all day on 26 and 27. He initially had a slight temperature, some chills, slight cough, runny nose and those symptoms except for the cough seem to have resolved, what hasn't resolved is about every 30 or 40 minutes or so he had been having to urinate ever since 26Feb2021 night, his mouth has been constantly very dry. Still urinating every half hour 45 minutes and ongoing. Mouth has been very dry and had a couple of areas where it seems like maybe he had bit his lip or something, maybe when he was sleeping. It was nothing like that in mouth anymore but the mouth is still constantly so dry like dehydrated and no matter how much of fluid he drank that doesn't seem to help it and what in fact has also caused was on yesterday morning he had been a little constipated on Friday night and then yesterday morning had a severe case of diarrhea. Now he had not had another bowel movement since yesterday morning as no appetite and feeling so lousy, and so tired and fatigued. He had been feeling even much worse since getting the vaccine. He still feels very fatigued, very sore all over, very tired, still have the slight cough and he would say that's about it. Outcome of events for cough, pain and tiredness was not recovered and for the rest of the events it was unknown. No follow-up attempts are possible. No further information is expected.

Other Meds: LISINOPRIL; AMLODIPINE; ROSUVASTATIN; REPATHA

Current Illness:

ID: 1254234
Sex: F
Age:
State: NJ

Vax Date: 02/16/2021
Onset Date: 02/21/2021
Rec V Date: 04/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Eczema; Rash on my leg, on the top of my front side and it was like itchy; This is a spontaneous report from a contactable consumer. This 63-years-old female consumer reported for herself that she received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/lot number: E19266), via an unspecified route of administration on 16Feb2021 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. On 21Feb2021, the patient got like a little rash on her leg, on the top of her front side and it was like very itchy. She thought it was little bit of eczema. The patient took cortisone cream over the counter for the event. The outcome of the event eczema was resolved In 2021 whereas other event was resolving.

Other Meds:

Current Illness:

ID: 1254235
Sex: F
Age:
State: NY

Vax Date: 02/19/2021
Onset Date: 02/19/2021
Rec V Date: 04/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: pain by my ear on my face/ lymph node; throbbing pain; swelling; experiencing discomfort; This is a spontaneous report from a contactable consumer (patient reported herself). A 58-Year-old non-pregnant female patient received second dose of BNT162B2 (COVID 19, Pfizer, Solution for injection) via an unspecified route of administration to her right arm on 19Feb2021 02:30 PM (Lot number: EN 6201) as single dose for Covid-19 immunization. The patient's medical history was not reported. Concomitant medications were reported as none. She was allergic to celecoxib (CELEBREX) (Known allergies: Celebrex). Other medical history was none. Facility type vaccine: Other. The patient previously took first dose of BNT162B2 (COVID 19, Pfizer) to her right arm on 29Jan2021 02:30 PM as single dose for Covid-19 immunization. Other medications in two weeks was reported none. It was reported that, on 19Feb2021 05:00 PM, three hours after receiving the second vaccine experienced pain by ear on face. With a little research she found out there was a lymph node called preauricular. She had throbbing pain and swelling. It was been three days since Covid shot and still experiencing discomfort. No Covid tested prior/post vaccination. The patient did not receive any treatment in response to the events. Outcome of the events was not recovered. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1254236
Sex: F
Age:
State: FL

Vax Date: 02/10/2021
Onset Date: 02/12/2021
Rec V Date: 04/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: with the second dose, swollen and cracked lips; dry mouth; This is a spontaneous report from a contactable consumer (patient). A 74-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EL9262), dose 2 via an unspecified route of administration in left arm on 10Feb2021 13:15 (at 74-years age) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. With the 1st dose, patient's lips were swollen and cracked and with the second dose, swollen and cracked lips, dry mouth on 12Feb2021. No treatment received for reported adverse event. Patient not tested for COVID-19 after the vaccination. The event outcome was reported as not resolved.

Other Meds:

Current Illness:

ID: 1254237
Sex: M
Age:
State: TX

Vax Date: 01/26/2021
Onset Date: 02/01/2021
Rec V Date: 04/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: urinary tract infection; 21Feb2021 tested positive for covid-19; 21Feb2021 tested positive for covid-19; had been sick and got sicker; This is a spontaneous report from a Pfizer-sponsored program via consumer (patient). A 74-years-old male patient received the first dose of BNT162B2 (Solution for injection, Lot number EL9262) on 26Jan2021. The patient experienced for a couple of weeks not feeling well with headaches, shortness of breath and congestion. On 21Feb2021, the patient tested positive for covid-19. Patient has been in bed and sick ever since. He has been sick for a total of over 3 weeks. Between 16Feb2021 and 22Feb2021 he had been sick and got sicker. The patient asked if it is ok to get the second dose on 09Mar2021. The events were treated with an antibiotic for a urinary tract infection. The outcome of the events was unknown. The patient was unable to make it back for the second vaccine on 17Feb2021 due to weather and power outages in his area then got the Covid virus during that time which postponed the second vaccine for the second time. They rescheduled the second dose for the following Monday, 22Feb2021. The patient underwent lab test which included COVID-19 test and the patient was tested positive for COVID-19.

Other Meds:

Current Illness:

ID: 1254238
Sex: M
Age:
State: TX

Vax Date: 02/05/2021
Onset Date: 02/23/2021
Rec V Date: 04/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: serious pain in shoulders; difficulty sleeping/Could not sleep; Major pain in groin area, shoulder and general leg; Major pain in groin area, shoulder and general leg/could not lift my legs to get out of bed without severe pain; arm weakness; Sometimes at night had severe chills; pain was very high; My temperature was usually between 98 and 99; This is a spontaneous report from a contactable consumer (patient). A male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 05Feb2021 07:30 (Batch/Lot Number: el9269) as SINGLE DOSE for covid-19 immunisation. Medical history included hypertension (medical history: High BP), CIDP in 2006. Concomitant medication(s) (in two weeks) included amlodipine besylate taken for an unspecified indication, start and stop date were not reported; atorvastatin taken for an unspecified indication, start and stop date were not reported; losartan taken for an unspecified indication, start and stop date were not reported. Historical Vaccine include BNT162B2 (Lot number: e13249, Administration time: 01:30 PM, Vaccine location: Left arm, Dose number: 1) and experienced Minor arm soreness at time of injection, 2 weeks after first injection sore neck and shoulder, soreness in upper body. The patient experienced serious pain in shoulders on an unspecified date, difficulty sleeping/could not sleep on an unspecified date, major pain in groin area, shoulder and general leg on an unspecified date, major pain in groin area, shoulder and general leg/could not lift my legs to get out of bed without severe pain on an unspecified date, arm weakness on an unspecified date, my temperature was usually between 98 and 99, sometimes at night had severe chills on an unspecified date, pain was very high on 23Feb2021. Adverse event: Minor arm soreness at time of injection. 2 weeks after first injection sore neck and shoulder. Neck so bad had to sleep upright in chair for several days. Was not consistent all time. 3 weeks after first injection, neck pain was better but overall soreness in upper body. 1 weeks after my second injection I had serious pain in shoulders and had difficulty sleeping. 2 weeks after 2nd injection had major pain in groin area, shoulder and general leg and arm weakness. Could not sleep. This continued off and on for 18 days after my second injection. My temperature was usually between 98 and 99 (normal is 97 or less). When temp spiked close to 99, pain was very high. Sometimes at night had severe chills. Been taking Tylenol for 5 days to keep temp down. I am slowly feeling better, but still have shoulder and groin soreness. At my worst with side effects, could not lift my legs to get out of bed without severe pain. The issues were not constant. Prior to vac, excellent health/active. Adverse event start date: 29Jan2021, Adverse event start time: 07:30 AM. If treatment AE: No. If covid prior vaccination: No, If covid tested post vaccination: No. Known allergies: no. Facility type vaccine: Hospital. If other vaccine in four weeks: No. The patient underwent lab tests and procedures which included body temperature: 99 on 2021. For all events, outcome was recovering and, for my temperature was usually between 98 and 99, outcome was recovered on an unspecified date.

Other Meds: AMLODIPINE BESYLATE; ATORVASTATIN; LOSARTAN

Current Illness:

ID: 1254239
Sex: F
Age:
State: IL

Vax Date: 02/28/2021
Onset Date: 03/01/2021
Rec V Date: 04/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Nausea; threw up bile; This is a spontaneous report from a contactable consumer (patient). A 35-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number: EN6205), at 35 years of age, via an unspecified route of administration on 28Feb2021 11:00 at single dose, in left arm for COVID-19 immunisation. The patient medical history included hypothyroidism and patient had allergic reaction hives to Ceclor. Concomitant medication was not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number: unknown), on unspecified date at single dose for COVID-19 immunisation. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient did not diagnosed with COVID-19 prior to vaccination. The patient had not tested positive for COVID-19 since having the vaccine. On 01Mar2021 03:00, the patient experienced nausea and threw up bile. The events were considered as non-serious. No treatment was given for the events. The outcome of the events was recovering. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1254240
Sex: F
Age:
State: IL

Vax Date: 12/19/2020
Onset Date: 01/07/2021
Rec V Date: 04/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: tested positive for COVID on 07Jan2021 which was two days before my second dose; tested positive for COVID on 07Jan2021 which was two days before my second dose; This is a spontaneous report from a contactable patient. A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection), via an unspecified route of administration on 19Dec2020 as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient received her Pfizer vaccine dose 1 on 19Dec2020. She tested positive for COVID on 07Jan2021 which was two days before her second dose of the vaccine. Her hospital was not sure whether she need just a second dose of the vaccine or if she should start the process over. Patient look forward to hearing your guidance on this matter. The outcome of the events was unknown. Information on lot/ batch number has been requested.

Other Meds:

Current Illness:

ID: 1254241
Sex: F
Age:
State:

Vax Date: 01/01/2021
Onset Date:
Rec V Date: 04/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Laboratory tests results confirmed that she was infected by the COVID-19 virus/she found to be an asymptomatic patient for COVID-19 infection; Laboratory tests results confirmed that she was infected by the COVID-19 virus/she found to be an asymptomatic patient for COVID-19 infection; she did not received the second dose of the Pfizer's COVID-19 vaccine; she did not received the second dose of the Pfizer's COVID-19 vaccine; Fever; This is a spontaneous report from a non-contactable consumer . This female consumer reported that she received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE (Solution for injection) via an unspecified route of administration as a single dose for COVID-19 immunization in the first week of January. The consumer reports that in Jan she was installed at a nursery home and there were multiple cases of COVID-19 infection that affected the staff and the members installed there. Two days after that she had fever but she was not admitted in the hospital despite the laboratory tests results confirmed that she was infected by the COVID-19 virus. The consumer reports that she found to be an asymptomatic patient for COVID-19 infection. The consumer reports that she was transferred to another nursery residence and because of that and her quarantine after being infected with the COVID-19 virus she did not received the second dose of the Pfizer's COVID-19 vaccine which led to missed dose and incomplete course of vaccination. The outcome for the events was unknown. The consumer reports that she spoke with agent before being transferred to Pfizer. AE for the missed second dose of the Pfizer's COVID-19 vaccine due to COVID-19 quarantine. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1254242
Sex: F
Age:
State: MD

Vax Date: 02/20/2021
Onset Date: 02/22/2021
Rec V Date: 04/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Rash; itching from the injection site; pain on right arm; swelling on the Right arm; This is a spontaneous report from a contactable consumer or other non hcp. A 76-years-old female patient received bnt162b2 (BNT162B2, Lot Number: EN6200), dose 2 via an unspecified route of administration, administered in Arm Right on 20Feb2021 13:15 as SINGLE DOSE for covid-19 immunisation. Medical history included asthma from an unknown date and unknown if ongoing Verbatim: Asthma, hypersensitivity from an unknown date and unknown if ongoing Verbatim: Allergy. On 22Feb2021, the patient experienced rash, itching from the injection site, pain on right arm, swelling on the right arm. The action taken in response to the event for bnt162b2 was not applicable. Therapeutic measures were taken as a result of rash. The outcome of the event rash was recovering, and rest event outcome was unknown. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1254243
Sex: M
Age:
State: NC

Vax Date:
Onset Date:
Rec V Date: 04/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: anxiety; This is a spontaneous report from a contactable consumer via Pfizer Company Representative. A 33-year-old male patient received bnt162b2 (UNSPECIFIED TRADE NAME, Solution for injection), dose 2 via an unspecified route of administration on an unspecified date (Lot Number: EL9265) at the age of 32 years old as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient began having anxiety the day after receiving his second dose of the Covid-19 vaccine. Event took place after use of product. The outcome of the event was unknown. Information about the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1254244
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 04/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: patient developed Covid-19; patient developed Covid-19; This is a spontaneous report from a Non contactable pharmacist. A male patient of an unspecified age received a first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number and expiration dates were not reported), via an unspecified route of administration on an unknown date as single dose for COVID-19 immunisation. The medical history and concomitant medications were not reported. The pharmacist reported that after patient received the 1st dose of the BioNTech Covid-19 Vaccine, the patient developed Covid-19 and pharmacist wants to know if it would still be okay if the patient receives the 2nd dose of the BioNTech Covid-19, 42 days or more after the 1st dose. The outcome of the event was unknown. No follow up attempts are possible. Information about Lot/batch number cannot be obtained.; Sender's Comments: Based on the known safety profile of the drug and a plausible temporal relationship, a causal association between the reported event and the suspect drug bnt162b2.

Other Meds:

Current Illness:

ID: 1254245
Sex: F
Age:
State: ME

Vax Date: 01/29/2021
Onset Date:
Rec V Date: 04/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Tumor in spine; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient's daughter) reported that a female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number and Expiration Date were not reported), via an unspecified route of administration, on 29Jan2021, at a single dose, for COVID-19 immunization. The patient's medical history included hip pain (prior to the first dose of the vaccine). The patient's concomitant medication included paracetamol (TYLENOL) for hip pain. The patient received the first dose of the Pfizer vaccine on 29Jan2021. The patient started taking 4 mg dexamethasone daily since 03Feb2021 (also reported as 02Feb2021 or 03Feb2021) for a tumor in spine on an unspecified date. The event was considered non-serious by the reporter. The patient received the second dose of the vaccine on 18Feb2021. The patient's daughter wanted to know if this will affect the efficacy of the vaccine as she has been seeing conflicting sources about it. The outcome of the event was unknown. Information about lot number and expiration date for the suspect product will be requested in follow-up attempts.

Other Meds: TYLENOL

Current Illness:

ID: 1254246
Sex: F
Age:
State: MO

Vax Date:
Onset Date:
Rec V Date: 04/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: felt sick; This is a spontaneous report from a Pfizer-sponsored program from a contactable consumer (patient). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. It was reported that second vaccine was scheduled today. Caller did not go because she felt sick. Inquiring was it okay to miss the vaccine after 21 days. The outcome of the event was unknown. Information about the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1254247
Sex: F
Age:
State: OH

Vax Date:
Onset Date:
Rec V Date: 04/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fever; This is a spontaneous report from a Pfizer sponsored program Support from a contactable consumer (patient). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously received the first dose of bnt162b2 for Covid-19 immunisation. The patient took her second dose yesterday and caught fever today and she wanted to know if she could take Ibuprofen. The outcome of the event was unknown. Information on the lot batch number has been requested.

Other Meds:

Current Illness:

ID: 1254248
Sex: F
Age:
State: CA

Vax Date: 02/07/2021
Onset Date:
Rec V Date: 04/25/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: head rush immediately after injection; extremely sore arm; This is a spontaneous report from a contactable consumer. This 65-year-old female consumer (patient) reported that: A 65-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 07Feb2021 10:00 as SINGLE DOSE for covid-19 immunisation. Medical history included, covid-19 covid prior vaccination: Yes. Concomitant medications included amlodipine taken for an unspecified indication, metformin hydrochloride taken for an unspecified indication, the patient previously took flagyl metronidazole and experienced drug hypersensitivity, ciprofloxacin, and experienced drug hypersensitivity. The patient experienced head rush immediately after injection, extremely sore arm and the events were assessed as Non serious by health authority and outcome of the events recovering No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: AMLODIPINE; METFORMIN ER

Current Illness:

Total 2021 VAERS Injuries: 599,999

Page last modified: 03 October 2021 5:28pm